Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-12-20 5:17 pm Sale | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 3,805,000 9.99% | -7,502,939 (-66.35%) | View |
| 2019-11-18 5:16 pm Sale | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 11,307,939 29.5% | -54,000 (-0.48%) | View |
| 2019-08-13 5:08 pm Purchase | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 11,361,939 40.3% | 11,361,939 (New Position) | View |
| 2019-08-07 5:28 pm Purchase | 13D | AQUINOX PHARMACEUTICALS INC AQXP | BAKER BROS. ADVISORS LP | 11,361,939 48.2% | 425,525 (+3.89%) | View |